NCT07470606 2026-03-13
MemoryRT
The University of Texas Health Science Center at San Antonio
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT07164794 2025-11-19
Memantine Hydrochloride in Prostate Cancer Patients
Zhongda Hospital
Phase 2 Not yet recruiting
NCT06789757 2025-10-07
(HCC)
Inova Health Care Services
Phase 2 Recruiting
NCT06727773 2025-09-02
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting
NCT05045950 2025-04-25
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
Medical College of Wisconsin
Phase 2 Recruiting
NCT06679387 2024-11-07
"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
Ain Shams University
Phase 2 Recruiting
NCT03194906 2023-07-13
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
St. Jude Children's Research Hospital
Phase 2 Completed
NCT04033419 2023-04-20
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT01535040 2021-09-28
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
Wake Forest University Health Sciences
Phase 2 Completed
NCT04801342 2021-03-17
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
National Taiwan University Hospital
Phase 2 Unknown
NCT01260467 2015-12-10
Memantine for Recurrent Glioblastoma
University of Rochester
Phase 2 Terminated